Advertisement
Screener

Immuneering Corporation (IMRX) Auditor

Immuneering Corporation Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-06: Fiscal year end 2025-12-31; Auditor RSM US LLP; PCAOB firm ID 49; Location Boston, Massachusetts.
  • 2025-03-20: Fiscal year end 2024-12-31; Auditor RSM US LLP; PCAOB firm ID 49; Location Boston, Massachusetts.
  • 2024-03-01: Fiscal year end 2023-12-31; Auditor RSM US LLP; PCAOB firm ID 49; Location Boston, Massachusetts.
  • 2023-03-06: Fiscal year end 2022-12-31; Auditor RSM US LLP; PCAOB firm ID 49; Location Boston, Massachusetts.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-062025-12-31RSM US LLP49Boston, MassachusettsNo
2025-03-202024-12-31RSM US LLP49Boston, MassachusettsNo
2024-03-012023-12-31RSM US LLP49Boston, MassachusettsNo
2023-03-062022-12-31RSM US LLP49Boston, MassachusettsNo
2022-03-102021-12-31RSM US LLP49Boston, MassachusettsNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quantum Cyber N.V. (QUCY)$0.113B
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
GENELUX Corp (GNLX)United States$0.110B-3.83
Equillium, Inc. (EQ)United States$0.109B-11.27
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80